International comparison of median age at death from cystic fibrosis

被引:63
作者
Fogarty, A [1 ]
Hubbard, R [1 ]
Britton, J [1 ]
机构
[1] Univ Nottingham, City Hosp, Div Resp Med, Nottingham NG5 1PB, England
关键词
cystic fibrosis; international; mortality; sex;
D O I
10.1378/chest.117.6.1656
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To compare international trends in mortality from cystic fibrosis. Design: Comparison of trends in median age at death using national mortality data. Setting: Data from 10 countries in North America, Europe, and Australasia. Participants: All persons registered as having died of cystic fibrosis in specified years from 1980 to 1994. Interventions: Comparison of relative odds of death at the international median age at death for the year of death between countries for two periods of time; from 1980 to 1987 (10 countries) and from 1980 to 1994 (7 countries). Measurements and results: The international median age at death increased fi om 8 years in 1974 to 21 years in 1994. Median age at death also increased within all countries, was consistently highest in the United States, and varied significantly by a factor of > twofold between countries. Women were significantly more likely to die at a younger age than the median age at death than men. Conclusions: Median age at death from cystic fibrosis is increasing, but our findings imply that clinically significant differences in survival with cystic fibrosis persist between countries.
引用
收藏
页码:1656 / 1660
页数:5
相关论文
共 13 条
[2]  
Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664
[3]   Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis [J].
Curtis, JR ;
Burke, W ;
Kassner, AW ;
Aitken, ML .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (06) :1921-1924
[4]   GENDER DIFFERENCES IN CYSTIC-FIBROSIS - PSEUDOMONAS-AERUGINOSA INFECTION [J].
DEMKO, CA ;
BYARD, PJ ;
DAVIS, PB .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (08) :1041-1049
[5]   Incidence, population, and survival of cystic fibrosis in the UK, 1968-95 [J].
Dodge, JA ;
Morison, S ;
Lewis, PA ;
Coles, EC ;
Geddes, D ;
Russell, G ;
Littlewood, JM ;
Scott, MT .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 77 (06) :493-496
[6]   THE CHANGING EPIDEMIOLOGY OF CYSTIC-FIBROSIS [J].
FITZSIMMONS, SC .
JOURNAL OF PEDIATRICS, 1993, 122 (01) :1-9
[7]   INCIDENCE AND MORTALITY-RATES OF CYSTIC-FIBROSIS IN JAPAN, 1969-1992 [J].
IMAIZUMI, Y .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 58 (02) :161-168
[8]   SEVERITY OF CYSTIC-FIBROSIS IN PATIENTS HOMOZYGOUS AND HETEROZYGOUS FOR DELTA-F508 MUTATION [J].
JOHANSEN, HK ;
NIR, M ;
HOIBY, N ;
KOCH, C ;
SCHWARTZ, M .
LANCET, 1991, 337 (8742) :631-634
[9]  
LUCOTTE G, 1995, HUM BIOL, V67, P797
[10]   Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study [J].
Mahadeva, R ;
Webb, K ;
Westerbeek, RC ;
Carroll, NR ;
Dodd, ME ;
Bilton, D ;
Lomas, DA .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7147) :1771-+